Si deseas distinguir tus productos, servicios o ambos de los de otra empresa, es posible que necesites una marca o nombre comercial. Descubre qué son, en qué consiste su procedimiento de registro y qué implica.
Información sobre los plazos de presentación de solicitudes de transformación de marcas de la Unión Europea en marca nacional española. Más información
Si tienes un nuevo dispositivo, producto o procedimiento que resuelva un problema técnico o tenga una ventaja práctica, existen distintas formas de protegerlo en España y en otros países. Descubre cómo hacerlo.
¿Tu innovación reside en la estética, la ornamentación o la apariencia de tu producto? Protégela mediante un diseño industrial. Descubre qué derechos confiere el registro y cómo realizar la tramitación.
Las indicaciones geográficas protegen el nombre de un producto originario de una zona geográfica, a la cual le debe una determinada calidad, reputación u otra característica. Descubre qué son, en qué consiste su procedimiento de registro y qué beneficios conceden.
Las patentes publicadas en todo el mundo son una valiosa fuente de información científica, técnica y comercial.
Si eres emprendedor/a o una empresa y quieres potenciar y mejorar la rentabilidad de tu negocio protegiendo de forma adecuada los activos intangibles de tu organización, en este espacio encontrarás lo necesario.
444
resultados
Última actualización
29/07/2026 [07:08:00]
Resultados 125 a 150 de 444
Resumen de: US20260199553A1
0000 The invention relates to a 3D adipose tissue scaffold for use as a breast implant for surgical, therapeutic, prophylactic or aesthetic restoration, reconstruction or replacement of human breast tissue, wherein the 3D adipose tissue scaffold comprises a matrix of a biocompatible polymer which is colonized with a plurality of biological cell types, the colonization with the plurality of cell types taking place during the construction of the matrix of biocompatible polymer with the formation of a blood vessel network within the 3D adipose tissue scaffold, characterized in that light-based, structuring curing of a photopolymerizable or photocrosslinkable liquid is used for the construction of the matrix of biocompatible polymer. The invention also relates to the use of a 3D adipose tissue scaffold as a breast implant in humans, wherein the 3D adipose tissue scaffold comprises a matrix of biocompatible polymer which is colonized with a plurality of cell types, wherein the colonization with the plurality of cell types takes place during the construction of the matrix of biocompatible polymer with the formation of a blood vessel structure network within the 3D adipose tissue scaffold, characterized in that light-based, structuring curing of a photopolymerizable or photocrosslinkable liquid is used for the construction of the matrix of biocompatible polymer.
Resumen de: US20260199095A1
The present invention relates to a big data-based artificial organ production system. The artificial organ production system according to the present invention includes: an input unit that receives user's requirements for the artificial organ to be produced as input values; a database unit that stores data necessary for producing the artificial organ; a control unit that produces the artificial organ by inputting the input values into the artificial organ production algorithm learned on the basis of the database unit; and a bioprinter that produces the artificial organ under the control of the control unit.
Resumen de: US20260199559A1
0000 Disclosed are implantable devices, systems, and methods of fabricating, testing, optimizing, and/or implanting such devices. An implantable device includes a body, a first intrinsic channel network formed in the body and configured to receive cells, and a second intrinsic channel network formed in the body and configured to allow for active flow of a fluid to support viability and/or function of the cells in the first intrinsic channel network. The first intrinsic channel network comprises a first channel and the second intrinsic channel network comprises a second channel, with at least segments of the first and second channels parallel to and spaced apart from each other. Cells may be suspended in a collagen matrix and introduced to the first intrinsic channel network.
Resumen de: AU2025286486A1
A moisture chamber adapted for use with eyeglasses. The moisture chamber is a single-use, disposable, component that is temporarily adhered to the inside of a the lens of a pair of glasses. The moisture chamber may be used on one or both of the lenses and works by creating a moist environment for the eye to help alleviate dry eyes. The moisture chamber may be made of silicon and may be 3-D printed.
Resumen de: US20260204408A1
The present disclosure provides a system for tracking hygiene products, comprising a plurality of hygiene products, each hygiene product having an associated tag, a reader configured to detect the tags associated with the hygiene products, and a point of care unit configured to receive tracking information from the reader. The point of care unit is further configured to track any of the time since a hygiene product was last replaced, moisture events, and rounding checks.
Resumen de: AU2024395361A1
Methods and apparatus for extracting coronary artery disease (CAD) information from unstructured medical text are provided. The method includes receiving unstructured medical text, processing the unstructured medical text using one or more trained natural language processing (NLP) models, wherein the one or more trained NLP models are trained to output CAD information, wherein the CAD information includes predicted coronary lesion information, and displaying an indication of the predicted coronary lesion information on a user interface associated with a computing device.
Resumen de: WO2024235974A1
A microneedle particle arranged to be rolled and massaged on a subject's skin (12) to penetrate the stratum corneum (14) is disclosed. The microparticle comprises a support body (20), and a plurality of microneedles (30) protruding from the support 5 body (20), each microneedle comprising a tip (40). The support body (20) maintains the microneedles (30) and tips (40) in a predetermined conformation allowing the microneedle particle to be rolled on the skin. The microneedles have an average tip sharpness radius of less than 20 µm, an average microneedle length of less than 100 µm, and an average tip sharpness to microneedle length ratio of 1:5 to 1:200. 10 Formulations and kits for said use are provided. A microneedle particle manufacturing method using a non-linear two-photon absorption process, a non- therapeutic cosmetic method of skin treatment, and a method of drug delivery through the skin for said microneedle particle are disclosed.
Resumen de: US20260204417A1
The present disclosure provides a method of facilitating AI-driven refinement of mental health diagnostics and personalized treatment. The method may include transmitting a prompt data to a user device. Further, the method may include receiving a mental health data from the user device based on the prompt data. Further, the mental health data may be associated with a user. Further, the method may include identifying a demography data based on the mental health data. Further, the method may include determining a diagnostic schema data to provide diagnostic insights based on the demography data. Further, the method may include generating a pre-diagnosis and/or diagnosis report data to provide personalized insights based on the diagnostic schema data and the mental health data. Further, the method may include transmitting the pre-diagnosis and/or diagnosis report data to the user device.
Resumen de: US20260199097A1
0000 An orthopaedic knee prosthesis includes a femoral component having a metal base with a polymer articular layer molded thereto. A method for making a metal-reinforced femoral component of an orthopaedic knee prosthesis is also disclosed.
Resumen de: WO2023159230A1
Systems and methods for distribution, storage, transport, administration and/or disposal of one or more therapeutic or diagnostic agents are disclosed. A storage device configured to connect to a delivery system for delivering the therapeutic or diagnostic agent has a housing with a chamber, a vessel having an access port positioned within the chamber. The door is movable relative to the housing between a closed position and an open position. In the closed position, the door covers an opening in the housing to enclose the chamber, and, in the open position, the door reveals the opening for accessing the access port of the vessel. The door is moveable between the closed position and the open position in response to actuation by an access mechanism of the delivery system.
Resumen de: US20260204399A1
0000 A system and method is described for printing a label with an RFID tag. The system includes an RFID reader that queries a first RFID tag coupled to a first medicinal container that includes a medication. In response, the system receives a first unique identifier and uses the first unique identifier to determine a status of the medication, associate the first medicinal container with a medical provider and print a second label that includes a second RFID tag for a second medicinal container.
Resumen de: US20260200168A1
0000 A method of forming a three-dimensional object, is carried out by (a) providing a carrier and a build plate, the build plate comprising a semipermeable member, the semipermeable member comprising a build surface with the build surface and the carrier defining a build region therebetween, and with the build surface in fluid communication by way of the semipermeable member with a source of polymerization inhibitor; (b) filling the build region with a polymerizable liquid, the polymerizable liquid contacting the build surface, (c) irradiating the build region through the build plate to produce a solid polymerized region in the build region, while forming or maintaining a liquid film release layer comprised of the polymerizable liquid formed between the solid polymerized region and the build surface, wherein the polymerization of which liquid film is inhibited by the polymerization inhibitor; and (d) advancing the carrier with the polymerized region adhered thereto away from the build surface on the build plate to create a subsequent build region between the polymerized region and the build surface while concurrently filling the subsequent build region with polymerizable liquid as in step (b). Apparatus for carrying out the method is also described.
Resumen de: AU2026205087A1
A patient interface includes a plenum chamber pressurizable to a therapeutic pressure, a seal-forming structure configured to form a seal against the patient’s face, and a positioning and stabilising structure configured to provide a force for maintaining the seal-forming structure in a therapeutically effective position. The patient interface also includes an RPT device connected directly to the plenum chamber. The PRT device includes an electric blower for providing airflow at the therapeutic pressure. The positioning and stabilising structure supports at least part of the weight of the RPT device. The patient interface may also include an electrical power source electrically connected to the RPT device. connected to the RPT device.20 un u n c o n n e c t e d t o t h e d e v i c e
Resumen de: US20260204383A1
Athletic activity monitoring methods and systems are disclosed. In one embodiment, a sensor module is physically coupled to an object during an athletic activity conducted by a user. An athletic activity monitoring method for use with the sensor module includes the steps of detecting movement of the object, recording movement data, identifying a matching athletic motion from a plurality of reference motions by comparing the movement data to data associated with the plurality of reference motions, and providing an output to the user that conveys the identity of the matching athletic motion.
Resumen de: US20260203900A1
0000 The present disclosure relates generally to medical imaging, and more specifically to machine-learning techniques for analyzing and generating medical images (e.g., to aid diagnosis and/or treatment of diseases). An exemplary method of displaying a predicted future state of a tissue of a subject includes receiving a fluorescence image of the tissue of the subject, providing the fluorescence image to a generator of a trained generative adversarial (“GAN”) model, obtaining, from the generator, a simulated white-light image depicting the predicted future state of the tissue of the subject, and displaying, on the display, the simulated white-light image depicting the predicted future state of the tissue of the subject.
Resumen de: US20260199036A1
An image-guided robotic intervention system ("IGRIS") may be used to perform medical procedures on patients. IGRIS provides a real-time view of patient anatomy, as well as an intended target or targets for the procedures, software that allows a user to plan an approach or trajectory path using either the image or the robotic device, software that allows a user to convert a series of 2D images into a 3D volume, and localizes the 3D volume with respect to real-time images during the procedure. IGRIS may include sensors to estimate pose of the imaging device relative to the patient to improve the performance of that software with respect to runtime, robustness, and accuracy.
Resumen de: US20260198787A1
A system and method for promoting and safeguarding the wellbeing of patients in relation to a fluid injection may obtain patient data; determine, based on the patient data, an initial risk prediction for a patient for a fluid injection to be administered to the patient, the initial risk prediction including a probability that the patient experiences at least one adverse event in response to the fluid injection; provide, to a user device, before the fluid injection is administered to the patient, the initial risk prediction; determine, after the fluid injection is started, sensor data associated with the patient; determine, based on the sensor data determined after the fluid injection is started, a current risk prediction including a probability that the patient experiences the at least one adverse event in response to the fluid injection; and provide, to the user device, the current risk prediction.
Resumen de: AU2026205158A1
- 55 - 22720713_1 (GHMatters) P116765.AU A system and method to collect feedback data from a patient wearing an interface such as a mask when using a respiratory pressure therapy device such as a CPAP device. The system includes a storage device including a facial image of the patient. An interface in communication with the respiratory pressure therapy device collect operational data from when the patient uses the interface. A patient interface collects subjective patient input data from the patient in relation to the patient interface. An analysis module correlates a characteristic of the interface with the facial image data, operational data and subjective patient input data. - 55 - un u n
Resumen de: US20260199047A1
0000 Many variations of systems, methods and apparatus for counting medical procedure objects, reconciling same, estimating patient blood loss during and/or after a procedure, and/or communicating between medical equipment used in a medical procedure setting are disclosed and/or illustrated herein. More particularly, many systems, methods and apparatus for counting and/or reconciling medical sponges with passive or active tracking devices, properly detecting/estimating blood loss during and/or after a medical procedure to assist with transfusion decision-making and identifying or at least alerting as to post-procedure patient risks, and/or for communicating between devices used during procedures to provide a smart/connected medical procedure environment are disclosed and/or illustrated herein.
Resumen de: US20260199563A1
Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.
Resumen de: US20260205408A1
Example embodiments of systems, devices, and methods are described for communication in an analyte monitoring system in accordance with an applicable communication protocol. A first device of the system may transmit a command to a second device of the system and the second device may encounter a processing delay in preparing data responsive to the command. The second device may transmit dummy data to the first device in order to maintain compliance with the communication protocol until such time that the second device is ready to transmit data responsive to the command. Numerous different embodiments for incorporating and/or accommodating the presence of dummy data in a communication hierarchy are provided.
Resumen de: US20260202498A1
0000 A method to reconstruct an image, from a magnetic resonance imaging (MRI) machine, with reduced sampling is provided. The method includes receiving a first indication corresponding to a support region, obtaining a set of data samples associated with the first indication, determining a subset of data samples, from the set of data samples, that does not overlap with the one or more regions having aliasing, generating a first reconstruction, based on the determined subset of data samples, generating a frequency representation corresponding to the first reconstruction, subtracting the frequency representation from the set of data samples, thereby generating a modified set of data samples, generating a second reconstruction, based on the modified set of data samples, generating a reduced sampling reconstruction corresponding to the support region, by combining the first and second reconstructions, and outputting the reduced sampling reconstruction.
Resumen de: US20260201474A1
0000 The present disclosure relates generally to methods for accurately predicting the risk of cancer-associated venous thromboembolism (CAT) and/or preventing CAT in cancer patients using ctDNA as a biomarker.
Resumen de: US20260204396A1
The present application relates to a computer-implemented medical method of determining a patient-specific setting of at least one imaging parameter of an imaging device. The method includes acquiring patient data describing information relating to a patient and having impact on the setting of at least one imaging parameter of the imaging device and acquiring object data describing at least one property of at least one object of interest associated with the anatomy of the patient. The imaging parameter data is determined based on the patient data, describing a patient-specific setting of the at least one imaging parameter of the imaging device.
Nº publicación: US20260199675A1 16/07/2026
Solicitante:
SIGNIFIER MEDICAL TECH LIMITED [GB]
Signifier Medical Technologies Limited
Resumen de: US20260199675A1
A device (100) for training oral muscle tone, the device (100) includes a mouthpiece (103) having a first and second arm (131) diverging away from one another and each carrying at least one electrode means (132a, 132b, 133a, 133b), at least one of the at least one electrode means protruding proud of adjacent portions of the arms (131), electrical circuitry operatively connected to the electrode means (132a, 132b, 133a, 133b), at least one of the at least one electrode means comprising an electrically conductive polymeric or plastics material.
BOPI
Sede Electrónica
